BRENDA CAMILO: Open Payments
NPI 1568196202 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,737 in 147 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,087 · 2025 $3,737
Food & beverage: $3,737
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $609 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $425 |
| Gilead Sciences, Inc. | 18 | $421 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $355 |
| Ardelyx, Inc. | 14 | $291 |
| QOL Medical, LLC | 9 | $284 |
| Phathom Pharmaceuticals, Inc. | 13 | $264 |
| Janssen Biotech, Inc. | 8 | $260 |
| Aimmune Therapeutics, Inc. | 12 | $259 |
| Madrigal Pharmaceuticals | 6 | $222 |
Products named: XIFAXAN, IBSRELA, Sucraid, ENTYVIO, VOQUEZNA, TREMFYA, REZDIFFRA, SKYRIZI.
Industry payments across RI — which companies pay providers there.
